Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
2.860
-0.060 (-2.05%)
At close: Oct 26, 2026, 4:00 PM EDT
2.840
-0.020 (-0.70%)
After-hours: Oct 26, 2026, 7:30 PM EDT
Entera Bio Market Cap
Entera Bio has a market cap or net worth of $497.42 million as of October 26, 2026. It is the 14,524th most valuable company in the world and the 2,734th biggest in the United States. Its market cap has increased by 390.55% in one year.
Market Cap
497.42M
Enterprise Value
486.53M
1-Year Change
390.55%
Global Rank
Country Rank
#2,734 United States
Category
ChartMarket Cap Chart
Since June 28, 2018, Entera Bio's market cap has increased from $71.40M to $497.42M, an increase of 596.66%. That is a compound annual growth rate of 26.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 497.42M | 458.90% |
| Dec 31, 2025 | 89.00M | 13.96% |
| Dec 31, 2024 | 78.10M | 351.45% |
| Dec 29, 2023 | 17.30M | -17.62% |
| Dec 30, 2022 | 21.00M | -74.07% |
| Dec 31, 2021 | 81.00M | 309.09% |
| Dec 31, 2020 | 19.80M | -23.85% |
| Dec 31, 2019 | 26.00M | -25.50% |
| Dec 31, 2018 | 34.90M | -51.12% |
| Jun 28, 2018 | 71.40M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Crescent Biopharma | 548.71M |
| Electra Therapeutics | 546.70M |
| Bright Minds Biosciences | 516.67M |
| CytomX Therapeutics | 505.53M |
| Valneva SE | 493.97M |
| Oculis Holding AG | 487.68M |
| Indaptus Therapeutics | 485.32M |
| Arvinas | 477.32M |